Happy Thanksgiving! We are deeply grateful for the incredible work done by the organizations we have supported this year. Your contributions have made a meaningful impact, and we are honored to be part of your mission. To our amazing team, thank you for your hard work, generosity, and passion. Your dedication has been inspiring and truly makes a difference every day. This season, in the spirit of giving and gratitude, we're excited to share stories of how our colleagues have embraced their Philosophy Days. Over the next few weeks, these inspiring tales will unfold, showcasing the heart and spirit of our community. From everyone at Pharmacosmos Therapeutics, we wish you a memorable holiday filled with cherished connections and gratitude. #PharmacosmosTherapeutics #CultureinAction #pticares
Pharmacosmos Therapeutics Inc.
制药业
Morristown，NJ 11,198 位关注者
Challenge Iron Deficiency Anemia
关于我们
Pharmacosmos Therapeutics Inc., an affiliate of Pharmacosmos, markets Monoferric in the US high-dose IV iron market. Pharmacosmos Therapeutics brings together: - A best-in-class product - Resources required to drive rapid growth - An ability to adapt quickly to market change - A new standard for patient care Founded in 1965, Pharmacosmos headquarters in Denmark. We are a family-held company built on passionate and knowledgeable people. We value integrity, open-mindedness, and respect. These values guide us in our endeavors and touch everyone in every part of our journey. We respect everyone who becomes a part of our journey. As a company , we strive to become the world leader in the treatment of iron deficiency anemia, one of the largest global health issues, and aspire to change the way iron deficiency anemia is treated. Pharmacosmos is focused on three business areas: branded pharmaceuticals, APIs, and carbohydrates. The US company focuses primarily on the prescription iron pharmaceutical market. Two-thirds of its revenue comes from this segment of the business. Pharmaceutical grade carbohydrates and API enhance their supply chain capabilities and overall market strategy and positioning. The company takes pride in our robust research and development program with a focus on human and veterinary medicines. Pharmacosmos cultivates a collaborative, performance-based culture. We recognize and reward employees for the value they bring and empower them to do meaningful work. Built upon the heritage and financial strength of the parent company, Pharmacosmos Therapeutics benefits from a singular focus, driving the growth of Monoferric.
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Morristown，NJ
- 类型
- 上市公司
- 创立
- 2019
- 领域
- iron deficiency anaemia和intravenous iron therapy
地点
-
主要
获取路线
US，NJ，Morristown，07960
Pharmacosmos Therapeutics Inc.员工
动态
-
We are excited to announce the completion of our acquisition of G1 Therapeutics, Inc. This acquisition fits perfectly with our strategy and positions our company for the next phase of growth. We are particularly thrilled to expand our product portfolio with G1’s lead product, an innovative, first-in-class therapy with the potential to make a real difference for patients with small cell lung cancer. Our focus will now be on bringing G1’s products to more patients in the US and eventually internationally. #G1Therapeutics #acquisition
-
Collective success is not possible without individual contribution. To our top performers—Thank you! Ben Ocasio is Specialty Account Representative of the Year. Welcome to President’s Club and congratulations! We are grateful for your elite collaboration and outstanding performance. #PharmacosmosTherapeutics #CultureinAction #PresidentsClub
-
-
Collective success is not possible without individual contribution. To our top performers—Thank you! Welcome back to President’s Club, Bobby Ponzo! Congratulations! We are grateful for your elite collaboration and outstanding performance. #PharmacosmosTherapeutics #CultureinAction #PresidentsClub
-
-
Collective success is not possible without individual contribution. To our top performers—Thank you! Welcome to President’s Club, Kermit Smith! Congratulations! We are grateful for your elite collaboration and outstanding performance. #PharmacosmosTherapeutics #CultureinAction #PresidentsClub
-
-
Collective success is not possible without individual contribution. To our top performers—Thank you! Welcome to President’s Club, Katie Green! Congratulations! We are grateful for your elite collaboration and outstanding performance. #PharmacosmosTherapeutics #CultureinAction #PresidentsClub
-
-
Collective success is not possible without individual contribution. To our top performers—Thank you! Welcome to President’s Club, Tracey Cooper! Congratulations! We are grateful for your elite collaboration and outstanding performance. #PharmacosmosTherapeutics #CultureinAction #PresidentsClub
-
-
Collective success is not possible without individual contribution. To our top performers—Thank you! Russell E. Veitenheimer is Regional Sales Director of the Year! Welcome to President’s Club! Congratulations. We are grateful for your elite collaboration and outstanding performance. #PharmacosmosTherapeutics #CultureinAction #PresidentsClub
-
-
Collective success is not possible without individual contribution. To our top performers—Thank you! Welcome to President’s Club, Paul Johnston! Congratulations! We are grateful for your elite collaboration and outstanding performance. #PharmacosmosTherapeutics #CultureinAction #PresidentsClub
-
-
Collective success is not possible without individual contribution. To our top performers—Thank you! Welcome back to President’s Club, Holly Judd, JD! Congratulations! We are grateful for your elite collaboration and outstanding performance. #PharmacosmosTherapeutics #CultureinAction #PresidentsClub
-